[1]
“Using profile of psychotropic drugs by users of the Psychosocial Care Center (CAPS) during the COVID-19 pandemic”, RSD, vol. 11, no. 8, p. e16711830697, Jun. 2022, doi: 10.33448/rsd-v11i8.30697.